Volume 81, Issue 7, Pages (April 2012)

Slides:

Advertisements

Similar presentations

Volume 83, Issue 2, Pages (February 2013)

Advertisements

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Urinary ammonia and long-term outcomes in chronic kidney disease

Anemia management in chronic kidney disease

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Volume 80, Issue 9, (November 2011)

Chronic Kidney Disease in Diabetes

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

Volume 80, Issue 1, Pages (July 2011)

John P. Middleton, Patrick H. Pun Kidney International

Volume 88, Issue 2, Pages (August 2015)

Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai Kidney International

Volume 77, Issue 8, Pages (April 2010)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Volume 77, Issue 1, Pages 5-6 (January 2010)

How to interpret the eGFR in patients with small body surface area

Volume 84, Issue 1, Pages (July 2013)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Ananda Chapagain, Hamish Dobbie, Michael Sheaff, Muhammad M. Yaqoob

Volume 82, Issue 3, Pages (August 2012)

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Volume 79, Issue 9, Pages (May 2011)

Volume 85, Issue 6, Pages (June 2014)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 75, Issue 1, Pages (January 2009)

U-shaped effect of eGFR and mortality

Volume 76, Issue 10, Pages (November 2009)

Volume 70, Issue 12, Pages (December 2006)

Volume 79, Issue 2, Pages (January 2011)

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.

Volume 76, Issue 5, Pages (September 2009)

Volume 73, Issue 12, Pages (June 2008)

Structure, not just function

Volume 76, Issue 6, Pages (September 2009)

Volume 81, Issue 6, Pages (March 2012)

Volume 76, Issue 3, Pages (August 2009)

Extracorporeal therapy in sepsis: are we there yet?

Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske

Volume 85, Issue 5, Pages (May 2014)

Methods for guideline development

Cardiovascular disease in pediatric chronic dialysis patients

Racial disparities in access to transplantation: a tough nut to crack

Volume 76, Issue 8, Pages (October 2009)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Nephrology Crossword: Glomerulonephritis

Volume 85, Issue 5, Pages (May 2014)

Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker

Volume 77, Issue 12, Pages (June 2010)

Volume 81, Issue 7, Pages (April 2012)

Volume 74, Issue 9, Pages (November 2008)

Volume 76, Issue 6, Pages (September 2009)

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Volume 81, Issue 12, Pages (June 2012)

The hypothesis that abnormal BH4 metabolism impairs kidney function

ANCA comes of age—but with caveats

Volume 75, Issue 7, Pages (April 2009)

Adiponectin: good, bad, or just plain ugly?

Friends, social networks, and progressive chronic kidney disease

Sugar-sweetened beverages and chronic disease

Volume 86, Issue 2, Pages (August 2014)

Presentation transcript:

Volume 81, Issue 7, Pages 684-689 (April 2012) Renal BOLD-MRI does not reflect renal function in chronic kidney disease Henrik J. Michaely, Linda Metzger, Stefan Haneder, Jan Hansmann, Stefan O. Schoenberg, Ulrike I. Attenberger Kidney International Volume 81, Issue 7, Pages 684-689 (April 2012) DOI: 10.1038/ki.2011.455 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Flowchart of the included patients. Kidney International 2012 81, 684-689DOI: (10.1038/ki.2011.455) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Graphic depiction of MR2* and CR2* distribution as a function of several parameters. Dot plots that demonstrate no correlation between the estimated glomerular filtration rate (eGFR) and medullary relaxation rate (MR2*) or cortical relaxation rate (CR2*) at (a) 1.5T or (b) 3.0T. Kidney International 2012 81, 684-689DOI: (10.1038/ki.2011.455) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 Graphic depiction of MR2* and CR2* distribution as a function of several parameters. In the subgroup analysis with patients stratified by renal function based on the Kidney Disease Outcomes Quality Initiative (KDOQI) groups, no significant differences between any of the groups can be appreciated at (a,c) 1.5T or (b,d) 3.0T. The symbols (x and +) represent outliers beyond the 75% confidence interval and were introduced by the statistical software. CR2*, cortical relaxation rate; MR2*, medullary relaxation rate. Kidney International 2012 81, 684-689DOI: (10.1038/ki.2011.455) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 4 Graphic depiction of MR2* and CR2* distribution as a function of several parameters. Dot plots that demonstrate no correlation between the age and medullary relaxation rate (MR2*) or cortical relaxation rate (CR2*) at (a) 1.5T or (b) 3.0T. Kidney International 2012 81, 684-689DOI: (10.1038/ki.2011.455) Copyright © 2012 International Society of Nephrology Terms and Conditions